This study provides valuable insights into how auditory stimuli influence the temporal dynamics of visual perception by modulating brain rhythms (oscillations) in the alpha band. The authors present ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma Kewalramani, M.D., to $21.5 million, according to the company’s proxy filing.

New Which? analysis has found that when it comes to the ever-growing menace of adverse weather, some insurers may be side-stepping some claims with definitions of 'floods' and 'storms' that conflict ...

Elastic (NYSE: ESTC), the Search AI Company, announced the general availability of the Elastic Google Cloud Vertex AI platform integration in Elastic Observability. This integration offers large ...

BOSTON, April 07, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets ...

Vertex Pharmaceuticals (VRTX) announced that the European Commission has granted regulatory approval for a label expansion of KAFTRIO in a combination regimen with ivacaftor for the treatment of ...

Gartner, Inc. has identified 12 emerging technology disruptions that will define the future of business systems. Technology leaders must prioritize these over the next five years, as they present ...

The Kentucky Antisemitism Task Force is trying to get at the roots of the problem in our state. ERIC PAUL ZAMORA ezamora@fresnobee.com Ultimately, policing constitutionally-protected free speech ...

It didn't take long for Chicago Bears general manager Ryan Poles to explain the type of prospect he's looking for in the 2025 NFL Draft. Chicago Bears general manager Ryan Poles appeared on a ...

To find a brief definition of the networking term you are looking for user your browser’s “Find” feature then follow links to a fuller explanation. AI networking refers to the application of ...

Vertex will not advance VX-264 further in clinical trials. Credit: Andrii Yalanskyi via Getty Images. Vertex Pharmaceuticals has discontinued the development of VX-264, a type 1 diabetes (T1D) cell ...